Electroacupuncture for the Treatment of Functional Constipation

Sponsor
Huazhong University of Science and Technology (Other)
Overall Status
Unknown status
CT.gov ID
NCT01781897
Collaborator
(none)
243
3
3
33.9
81
2.4

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the effect of electroacupuncture on functional constipation.

Condition or Disease Intervention/Treatment Phase
Phase 1

Detailed Description

This study will supply significant evidence for using acupuncture to treat functional constipation(FC), and will help us to identify whether it is a therapeutic effect rather than a placebo effect.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
243 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomized Controlled Trial of Acupuncture to Treat Functional Constipation
Study Start Date :
Feb 1, 2013
Anticipated Primary Completion Date :
Dec 1, 2015
Anticipated Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: mosapride

mosapride

Drug: mosapride
Mosapride Citrate tablet(5mg),Dainippon Sumitomo pharmaceutical Co.Ltd,Japan
Other Names:
  • GASMOTIN
  • Experimental: Electro-acupuncture

    Electro-acupuncture

    Device: acupuncture
    sterile, disposable needles with a length of 40 mm and a diameter of 0.25 mm (Dongbang® Acupuncture Inc, Korea)
    Other Names:
  • Park true/sham devices
  • Sham Comparator: mosapride + sham acupuncture

    mosapride + sham acupuncture

    Device: acupuncture
    sterile, disposable needles with a length of 40 mm and a diameter of 0.25 mm (Dongbang® Acupuncture Inc, Korea)
    Other Names:
  • Park true/sham devices
  • Drug: mosapride
    Mosapride Citrate tablet(5mg),Dainippon Sumitomo pharmaceutical Co.Ltd,Japan
    Other Names:
  • GASMOTIN
  • Outcome Measures

    Primary Outcome Measures

    1. number of defecation per week [3 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:
    • functional constipation according to the Roman Ⅲ standard;

    • aged between 18 and 65 years old

    Exclusion criteria:
    • unconsciousness, psychosis or can't express subjective symptoms;

    • pregnant women or women in lactation period;

    • serious diseases of the heart, liver, kidney, and others;

    • bleeding disorders.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital of Huazhong University of Science and Technology Wuhan Hubei China 430000
    2 Hubei Provincial Hospital of TCM Wuhan Hubei China 430000
    3 Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei China 430030

    Sponsors and Collaborators

    • Huazhong University of Science and Technology

    Investigators

    • Principal Investigator: Xiaohu Xu, Doctor, HUST(Huazhong University of Science and Technology) Hospital
    • Principal Investigator: Feng Hu, Master, Hubei Hospital of Traditional Chinese Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Guangying Huang, professor, Huazhong University of Science and Technology
    ClinicalTrials.gov Identifier:
    NCT01781897
    Other Study ID Numbers:
    • 2011CB505203-1
    First Posted:
    Feb 1, 2013
    Last Update Posted:
    Mar 19, 2015
    Last Verified:
    Apr 1, 2014
    Keywords provided by Guangying Huang, professor, Huazhong University of Science and Technology
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 19, 2015